Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fenaux

Showing results (241-250 of 320) with videos related to

Pageof 32
Sort By:
Cancer Genetics and Cytogenetics|January 1, 1989
Translocation t(1;19)(q23;p13) in acute lymphoblastic leukemia. A report on six new cases and an unusual t(17;19)(q11;q13), with special reference to prognostic factorsJ L Laï, P Fenaux, M H Estienne, et al.
Leukemia|January 28, 2005
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)H Leroy, S de Botton, N Grardel-Duflos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patientsF Morschhauser, J M Cayuela, S Martini, et al.
Cancer Genetics and Cytogenetics|September 1, 1990
Chronic myeloid leukemia with unusual variant Ph translocation (22;22)(q11;q13). Two cases with chimeric BCR-ABL transcriptsJ L Laï, Z Aissaoui, C Collyn-d'Hooghe, et al.
Oncogene|November 23, 2011
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemiaM Tailler, L Senovilla, E Lainey, et al.
Oncogene|October 23, 2012
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemiaE Lainey, A Wolfromm, N Marie, et al.
Cancer Causes & Control : CCC|November 28, 2007
UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control studyL Grandin, L Orsi, X Troussard, et al.
Leukemia|June 26, 2015
Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependentF Zassadowski, K Pokorna, N Ferre, et al.
Leukemia|July 30, 2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experienceI Lobe, F Rigal-Huguet, A Vekhoff, et al.
Leukemia|January 1, 1990
Polymorphism of the proto-oncogene ETS-1 in hematological malignanciesJ P Kerckaert, M Duterque-Coquillaud, M Collyn-d'Hooghe, et al.
Pageof 32

Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Cancer Genetics and Cytogenetics|January 1, 1989
Translocation t(1;19)(q23;p13) in acute lymphoblastic leukemia. A report on six new cases and an unusual t(17;19)(q11;q13), with special reference to prognostic factorsJ L Laï, P Fenaux, M H Estienne, et al.
Leukemia|January 28, 2005
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)H Leroy, S de Botton, N Grardel-Duflos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patientsF Morschhauser, J M Cayuela, S Martini, et al.
Cancer Genetics and Cytogenetics|September 1, 1990
Chronic myeloid leukemia with unusual variant Ph translocation (22;22)(q11;q13). Two cases with chimeric BCR-ABL transcriptsJ L Laï, Z Aissaoui, C Collyn-d'Hooghe, et al.
Oncogene|November 23, 2011
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemiaM Tailler, L Senovilla, E Lainey, et al.
Oncogene|October 23, 2012
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemiaE Lainey, A Wolfromm, N Marie, et al.
Cancer Causes & Control : CCC|November 28, 2007
UV radiation exposure, skin type and lymphoid malignancies: results of a French case-control studyL Grandin, L Orsi, X Troussard, et al.
Leukemia|June 26, 2015
Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK/ERK dependentF Zassadowski, K Pokorna, N Ferre, et al.
Leukemia|July 30, 2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experienceI Lobe, F Rigal-Huguet, A Vekhoff, et al.
Leukemia|January 1, 1990
Polymorphism of the proto-oncogene ETS-1 in hematological malignanciesJ P Kerckaert, M Duterque-Coquillaud, M Collyn-d'Hooghe, et al.
Pageof 32